AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 47 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 2.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,814 | -7.3% | 12,950 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $21,368 | +50.0% | 12,950 | +3.6% | 0.01% | +33.3% |
| Q1 2023 | $14,250 | +26.4% | 12,500 | 0.0% | 0.01% | +20.0% |
| Q4 2022 | $11,276 | -19.5% | 12,500 | 0.0% | 0.01% | -16.7% |
| Q3 2022 | $14,000 | +100.0% | 12,500 | 0.0% | 0.01% | +100.0% |
| Q2 2022 | $7,000 | – | 12,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $11,479,000 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 695,258 | $813,000 | 2.80% |
| Latash Investments, LLC | 243,134 | $284,000 | 0.23% |
| Bracebridge Capital, LLC | 428,571 | $501,000 | 0.09% |
| Running Point Capital Advisors, LLC | 10,000 | $12,000 | 0.01% |
| D.B. Root & Company, LLC | 12,500 | $14,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 406,700 | $475,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 142,956 | $167,000 | 0.00% |
| IFP Advisors, Inc | 6,500 | $104,000 | 0.00% |
| Financial Advocates Investment Management | 27,000 | $32,000 | 0.00% |